New perspectives on the treatment of skeletal dysplasia
Pauline Marzin1, Valérie Cormier-Daire2
1Clinical Genetics, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, IMAGINE Institute, Necker Enfants Malades Hospital, Paris, France.
Abstract:
The last few decades have been marked by the identification of numerous genes implicated in genetic disorders, helping in the elucidation of the underlying pathophysiology of these conditions. This has allowed new therapeutic approaches to emerge such as cellular therapy, gene therapy, or pharmacological therapy for various conditions. Skeletal dysplasias are good models to illustrate these scientific advances. Indeed, several therapeutic strategies are currently being investigated in osteogenesis imperfecta; there are ongoing clinical trials based on pharmacological approaches, targeting signaling pathways in achondroplasia and fibrodysplasia ossificans progressiva or the endoplasmic reticulum stress in metaphyseal dysplasia type Schmid or pseudoachondroplasia. Moreover, the treatment of hypophosphatasia or Morquio A disease illustrates the efficacy of enzyme drug replacement. To provide a highly specialized multidisciplinary approach, these treatments are managed by reference centers. The emergence of treatments in skeletal dysplasia provides new perspectives on the prognosis of these severe conditions and may change prenatal counseling in these diseases over the coming years.
Insights
Genetic discoveries are driving new treatments for skeletal dysplasias, including gene and cellular therapies. These advances offer hope for improved prognoses and prenatal counseling for rare genetic bone disorders.
Area of Science:
- Genetics and Molecular Biology
- Developmental Biology
- Medical Genetics
Background:
- Recent decades have seen significant gene identification for genetic disorders, advancing pathophysiology understanding.
- This progress has spurred the development of novel therapeutic strategies like cellular, gene, and pharmacological therapies.
- Skeletal dysplasias serve as key models for demonstrating these scientific and therapeutic advancements.
Purpose of the Study:
- To highlight the impact of genetic discoveries on the treatment of skeletal dysplasias.
- To showcase emerging therapeutic strategies for various skeletal dysplasia conditions.
- To discuss the implications of new treatments on patient prognosis and prenatal counseling.
Main Methods:
- Review of current research and clinical trials in skeletal dysplasia therapeutics.
- Analysis of gene identification and its role in understanding disease pathophysiology.
- Examination of specific therapeutic approaches, including gene therapy, cell therapy, and enzyme replacement therapy.
Main Results:
- Multiple therapeutic strategies are under investigation for conditions like osteogenesis imperfecta.
- Pharmacological approaches targeting signaling pathways and endoplasmic reticulum stress are being explored for achondroplasia, fibrodysplasia ossificans progressiva, and other dysplasias.
- Enzyme replacement therapy has shown efficacy in treating hypophosphatasia and Morquio A disease.
Conclusions:
- Emerging treatments for skeletal dysplasias offer new hope and improved outlooks for patients.
- These advancements necessitate specialized, multidisciplinary care managed by reference centers.
- The development of effective treatments is poised to significantly alter prenatal counseling for these severe genetic conditions.
More Related Videos
Related Concept Videos
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:40Bone Remodeling
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...